Comparison results
Results: Differences General | ✘D62 | ✘C93.1 | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
acute blood loss | 94% | — | ||||||||||
chronic monocytic leukemia | — | 84% | ||||||||||
blood loss | 79% | — | ||||||||||
mchc reduced | — | 70% | ||||||||||
bleeding | 69% | — | ||||||||||
leukocyturia | — | 58% | ||||||||||
latent iron deficiency | 63% | — | ||||||||||
alcoholism | — | 57% | ||||||||||
hypochromia | 62% | — | ||||||||||
acute leukemia | — | 55% | ||||||||||
iron deficiency anemia | 62% | — | ||||||||||
monocytosis | — | 55% | ||||||||||
thrombocytopathy | 55% | — | ||||||||||
alcohol dependence | — | 53% | ||||||||||
anemia | 73% | 16% | ||||||||||
proteinuria | — | 53% | ||||||||||
allergic vasculitis | 52% | — | ||||||||||
professional cancer | — | 45% | ||||||||||
aplastic anemia | 51% | — | ||||||||||
onset of illness | — | 42% | ||||||||||
monthly abundant and prolonged | 50% | — | ||||||||||
thrombocytopenia | — | 34% | ||||||||||
very abundant monthly | 50% | — | ||||||||||
waldenstrom 's macroglobulinemia | — | 33% | ||||||||||
pulmonary hemorrhage | 48% | — | ||||||||||
chronic myeloid leukemia | — | 31% | ||||||||||
dic syndrome | 44% | — | ||||||||||
increased gamma globulins | — | 28% | ||||||||||
dizziness when getting | 44% | — | ||||||||||
subacute condition | — | 24% | ||||||||||
coagulopathy | 43% | — | ||||||||||
chronic leukemia | — | 23% | ||||||||||
palpitations with shortness of breath | 43% | — | ||||||||||
hepatosplenomegaly | — | 22% | ||||||||||
trauma | 43% | — | ||||||||||
enlargement of the liver and spleen | — | 21% | ||||||||||
menstruation disorder | 42% | — | ||||||||||
very correct | — | 21% | ||||||||||
lack of breath | 39% | — | ||||||||||
enlargement of the spleen | — | 21% | ||||||||||
no strength | 39% | — | ||||||||||
increased ESR | — | 20% | ||||||||||
dehydration | 37% | — | ||||||||||
enlarged liver | — | 19% | ||||||||||
hemorrhagic diathesis | 36% | — | ||||||||||
tuberculosis | — | 19% | ||||||||||
dyspnea | 35% | — | ||||||||||
leukocytosis | — | 18% | ||||||||||
palpitations | 34% | — | ||||||||||
feeling of heat | — | 17% | ||||||||||
consequences of injuries | 34% | — | ||||||||||
metastases | — | 16% | ||||||||||
blood diseases | 64% | 31% | ||||||||||
high temperature | — | 16% | ||||||||||
oncology | 29% | — | ||||||||||
childhood diseases | — | 16% | ||||||||||
consequences of taking medications | 29% | — | ||||||||||
erythrocytic anemia | 62% | 32% | ||||||||||
leukemia | 43% | 18% | ||||||||||
hemorrhagic syndrome | 48% | 25% | ||||||||||
chronic anemia | 40% | 21% | ||||||||||
cancer | 32% | 15% |
Instructions
Video
|